A universal drug target for ovarian cancer
The discovery of a blood vessel-promoting protein interaction found in all ovarian tumors may lead to a new druggable target for ovarian cancers.
News
T cell memory tips off early stages of Parkinson’s disease
T cell memory tips off early stages of Parkinson’s disease
T cells that react to a Parkinson’s disease-linked protein have an early, unique, and detectable gene signature.
Digital technology reveals the secrets to treating neurological disorders
Digital technology reveals the secrets to treating neurological disorders
A biotech start-up teamed up with technology giants like Apple to continuously monitor people with Parkinson’s disease so that they could personalize their treatments in the clinic and the lab.
Patient cells and serum create better Alzheimer’s disease models
Patient cells and serum create better Alzheimer’s disease models
Many potential treatments for Alzheimer’s disease have been found using mouse models, but they often don’t translate well to humans. Will organoids provide the answers that neuroscientists need to develop new treatments?
A molecular nose sniffs out ovarian cancer
A molecular nose sniffs out ovarian cancer
Researchers developed a carbon nanotube-based sensor paired with a machine learning algorithm to diagnose ovarian cancer with better specificity and sensitivity than current methods.
A nanoengineered heart chamber
A nanoengineered heart chamber
A new heart-on-a-chip gives scientists an up-close look at the beating human heart from the comfort of their lab benches.
Predicting immune responses to vaccination
Predicting immune responses to vaccination
Armed with a machine learning and systems biology approach, John Tsang studies how past infections and vaccinations shape an individual’s immune response to future vaccines.
